Serum insulin-like growth factor-1 levels in response to dasatinib-based regimens in bone-metastatic prostate cancer.
Farshid Dayyani
No relevant relationships to disclose
Andreas Varkaris
No relevant relationships to disclose
John C. Araujo
No relevant relationships to disclose
Jian H. Song
No relevant relationships to disclose
Geralyn C. Trudel
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Christopher Logothetis
No relevant relationships to disclose
Gary E. Gallick
No relevant relationships to disclose